Zdrowie i gospodarka · 01/10/2009
FDA Proposes Rule on Postmarketing Safety Reporting for Combination Products
The FDA is proposing a rule to clarify postmarketing safety reporting requirements for combination products, aiming to protect public health and ensure consistency in regulatory requirements.
Source: Federal Register — Food and Drug AdministrationOpen original release →